Kandalaft, H.
24  results:
Search for persons X
?
1

Disulfide linkage engineering for improving biophysical pro..:

Kim, D. Y. ; Kandalaft, H. ; Ding, W....
Protein Engineering Design and Selection.  25 (2012)  10 - p. 581-590 , 2012
 
?
3

Routine pathologic parameters can predict Oncotype DXTM rec..:

Allison, K. H. ; Kandalaft, P. L. ; Sitlani, C. M...
Breast Cancer Research and Treatment.  131 (2011)  2 - p. 413-424 , 2011
 
?
5

Anomalous origin of the sinus nodal artery from left main a..:

Kandalaft, Naji ; Ro, Jae H. ; Weiss, Melvin B..
Catheterization and Cardiovascular Diagnosis.  23 (1991)  3 - p. 202-204 , 1991
 
?
7

182P Cancer vaccines based on whole-tumor-lysate or neoepit..:

Kandalaft, L. ; Fritah, H. ; Graciotti, M....
Immuno-Oncology and Technology.  16 (2022)  - p. 100294 , 2022
 
?
8

List of contributors:

, In: Cancer Vaccines as Immunotherapy of Cancer,
Adamik, Juraj ; Aurisicchio, Luigi ; Bell, John C.... - p. xi-xiii , 2022
 
?
9

List of Contributors:

, In: New Materials in Civil Engineering,
 
?
11

Cancer vaccines based on whole-tumor lysate or neoepitopes ..:

Fritah, H ; Graciotti, M ; Lai-Lai Chiang, C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.isci.2023.106288.  , 2023
 
?
12

Author Correction: Personalized cancer vaccine strategy eli..:

Tanyi, J.L ; Chiang, C.L ; Chiffelle, J...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41541-021-00332-5.  , 2021
 
?
13

Cell-autonomous inflammation of BRCA1-deficient ovarian can..:

Bruand, M ; Barras, D ; Mina, M...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.celrep.2021.109412.  , 2021
 
?
14

Personalized cancer vaccine strategy elicits polyfunctional..:

Tanyi, J.L ; Chiang, C.L ; Chiffelle, J...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41541-021-00297-5.  , 2021
 
?
15

Deciphering the Mechanisms of Improved Immunogenicity of Hy..:

Graciotti, M ; Marino, F ; Pak, H...
info:eu-repo/semantics/altIdentifier/doi/10.3390/vaccines8020271.  , 2020
 
1-15